SBVA

SBVA, formerly SoftBank Ventures Asia, is a South Korea-based venture capital firm focused on early- to mid-stage technology investing. Founded in 2000 as SoftBank Group's early-stage venture investment arm, it later became an independent entity and rebranded as SBVA after being acquired by The Edgeof. The firm invests broadly across sectors such as enterprise software, AI, robotics, computing, industrial deep tech, and healthcare technology rather than developing therapeutic products itself. For a biotech analyst, SBVA is best understood as an investor in healthtech and technology-enabled healthcare companies, not as an operating biotech, pharma, or healthcare services company.